SCHEMBL19459536

SCHEMBL19459536

CC1(C)O[C@@H]2C(n3cnc4c(N)nc(Cl)nc43)[C@H]3C[C@@]3(CP=O)[C@@H]2O1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 7/20 0.54
▸ HSP90B1 P14625 6/20 0.54
▸ ADORA1 P30542 5/20 0.54
▸ ADORA2A P29274 3/20 0.54
▸ HSP90AA1 P07900 2/20 0.54
▸ TMEM97 Q5BJF2 1/20 0.54
▸ SIGMAR1 Q99720 1/20 0.54
▸ P2RY1 P47900 3/20 0.50
▸ HRH2 P25021 1/20 0.48
▸ HTR5A P47898 1/20 0.48
▸ P2RY2 P41231 1/20 0.47
▸ HTR2B P41595 3/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ TMIGD3 P0DMS9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19799169 1.00 ADORA3 (0.54) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL19459932 0.91 HRH2 (0.49) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL19799166 0.91 HRH2 (0.49) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL12269824 0.89 ADORA3 (0.66) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL12269821 0.89 ADORA3 (0.56) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL19799167 0.88 P2RY1 (0.53) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL19459509 0.88 P2RY1 (0.53) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL12269843 0.87 ADORA3 (0.59) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL19415078 0.85 P2RY1 (0.53) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1
SCHEMBL12269762 0.85 P2RY1 (0.53) ADORA3HSP90B1ADORA1ADORA2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9789131-B1 Compounds and methods for treating neurological and cardiovascular conditions ASTROCYTE PHARMACEUTICALS, INC. (US) 2017-10-17 — — US disclosed
Send feedback